Solvonis Therapeutics PLC Ordinary Share (SVNS)

Industry Specialty Industrial Machinery


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.24p

Buy

0.26p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 16:25 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Income statement

20232024
587,000-
258,000-
-2m-2m
-376.49-
-3m-2m
-3m-1m
Sales, General and administrative677,000796,000
Interest expenses3,00064,000
Provision for income taxes--
Operating expenses2m2m
Income before taxes-3m-1m
Net income available to common shareholders-3m-2m
-0.03-0.00125
Net interest income-3,000-64,000
Advertising and promotion--
Net investment income, net-69,000-
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.03-0.00125
Free cash flow per share-0.0191-0.0061
Book value/share0.03330.0007
Debt equity ratio0.010859-

Balance sheet

20232024
Current assets314,000815,000
Current liabilities386,000119,000
Total capital2m3m
Total debt34,000-
Total equity2m3m
Total non current liabilities--
Loans--
Total assets2m3m
Total liabilities--
Cash and cash equivalents155,000757,000
Common stock104m2,296m

Cash flow

20232024
Cash at beginning of period2m155,000
Cash dividends paid--
-1m-1m
Investments (gains) losses-232,000-337,000
155,000757,000
Net income--
-1m-1m
-232,000-4,000
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.